Kaul Michael Gerhard, Mummert Tobias, Jung Caroline, Salamon Johannes, Khandhar Amit P, Ferguson R Matthew, Kemp Scott J, Ittrich Harald, Krishnan Kannan M, Adam Gerhard, Knopp Tobias
Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center, Hamburg-Eppendorf, Germany.
Phys Med Biol. 2017 May 7;62(9):3454-3469. doi: 10.1088/1361-6560/aa5780. Epub 2017 Jan 6.
Optimizing tracers for individual imaging techniques is an active field of research. The purpose of this study was to perform in vitro and in vivo magnetic particle imaging (MPI) measurements using a new monodisperse and size-optimized tracer, LS-008, and to compare it with the performance of Resovist, the standard MPI tracer. Magnetic particle spectroscopy (MPS) and in vitro MPI measurements were performed in concerns of concentration and amount of tracer in a phantom. In vivo studies were carried out in healthy FVB mice. The first group (n = 3) received 60 µl LS-008 (87 mM) and the second (n = 3) diluted Resovist of the same concentration and volume. Tracer injections were performed with a syringe pump during a dynamic MPI scan. For anatomic referencing MRI was applied beforehand of the MPI measurements. Summing up MPS examinations and in vitro MPI experiments, LS-008 showed better sensitivity and spatial resolution than Resovist. In vivo both tracers can visualize the propagation of the bolus through the inferior vena cava. MPI with LS-008 did show less temporal fluctuation artifacts and the pulsation of blood due to respiratory and cardiac cycle was detectable. With LS-008 the aorta was distinguishable from the caval vein while with Resovist this failed. A liver vessel and a vessel structure leading cranially could only be observed with LS-008 and not with Resovist. Beside these structural advantages both tracers showed very different blood half-life. For LS-008 we found 88 min. Resovist did show a fast liver accumulation and a half-life of 13 min. Only with LS-008 the perfusion fraction in liver and kidney was measureable. MPI for angiography can be significantly improved by applying more effective tracers. LS-008 shows a clear improvement concerning the delineation while resolving a larger number of vessels in comparison to Resovist. Therefore, in aspects of quality and quantity LS-008 is clearly favorable for angiographic and perfusion studies.
为个体成像技术优化示踪剂是一个活跃的研究领域。本研究的目的是使用一种新的单分散且尺寸优化的示踪剂LS - 008进行体外和体内磁粒子成像(MPI)测量,并将其与标准MPI示踪剂Resovist的性能进行比较。针对体模中示踪剂的浓度和用量进行了磁粒子光谱(MPS)和体外MPI测量。在健康的FVB小鼠中进行了体内研究。第一组(n = 3)接受60 μl LS - 008(87 mM),第二组(n = 3)接受相同浓度和体积的稀释Resovist。在动态MPI扫描期间用注射泵进行示踪剂注射。在进行MPI测量之前先进行MRI解剖定位。综合MPS检查和体外MPI实验,LS - 008显示出比Resovist更好的灵敏度和空间分辨率。在体内,两种示踪剂都能显示团注通过下腔静脉的传播。使用LS - 008的MPI显示出较少的时间波动伪影,并且由于呼吸和心动周期导致的血液搏动是可检测的。使用LS - 008时主动脉可与腔静脉区分开,而使用Resovist则无法区分。只有使用LS - 008才能观察到肝血管和一条向头侧走行的血管结构,而使用Resovist则观察不到。除了这些结构优势外,两种示踪剂的血液半衰期也非常不同。对于LS - 008,我们发现其半衰期为88分钟。Resovist确实显示出快速的肝脏蓄积,半衰期为13分钟。只有使用LS - 008才能测量肝脏和肾脏的灌注分数。通过应用更有效的示踪剂,用于血管造影的MPI可以得到显著改善。与Resovist相比,LS - 008在描绘方面有明显改善,同时能分辨更多的血管。因此,在质量和数量方面,LS - 008显然有利于血管造影和灌注研究。